Depressive disorders and their correction in complex treatment of metabolic syndrome patients
Aim. To study clinical and metabolic effects of selective serotonin re‑uptake inhibitor (SSTI) sertraline in complex treatment of metabolic syndrome (MS) patients. Material and methods. Thirty‑six MS patients were divided into two groups, according to treatment program and psychological symptoms. In...
Saved in:
| Main Authors: | Yu. P. Uspensky, E. V. Balukova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effectiveness of behavioral activation and antidepressant medication on the reduction of suicidality in patients with major depressive disorder
by: Latif Moradveisi, et al.
Published: (2025-07-01) -
Comparison of the Effect of Sertraline and Escitalopram on the Treatment of Major Depressive Disorder in Hemodialysis Patients: A Randomized Controlled Trial
by: Tahereh Sabaghian, et al.
Published: (2024-09-01) -
Metabolic Syndrome in Patients with Depression: A Cross-sectional Comparative Study
by: Ajay Prakash, et al.
Published: (2023-02-01) -
Mechanisms of formation comorbidity depression and obesity
by: G. E. Mazo, et al.
Published: (2018-07-01) -
THE CHOICE OF ANTIDEPRESSANTS FOR THE TREATMENT OF DEPRESSIVE DISORDERS ASSOCIATED WITH EPILEPSY
by: L. V. Lipatova, et al.
Published: (2016-12-01)